Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.3K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.3K
Hazard Rate01:11

Hazard Rate

515
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
515
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

757
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
757
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

493
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
493
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

987
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
987
Censoring Survival Data01:09

Censoring Survival Data

668
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
668

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Priorities for the development of a new rapid diagnostic test for patients with fever: a cross-sectional online survey among hospital physicians across Europe.

BMJ open·2026
Same author

A Bayesian life-course linear structural equations model (BLSEM) to explore the development of body mass index (BMI) from the prenatal stage until middle age.

International journal of obesity (2005)·2025
Same author

Discussion on "LEAP: the latent exchangeability prior for borrowing information from historical data" by Ethan M. Alt, Xiuya Chang, Xun Jiang, Qing Liu, May Mo, H. Amy Xia, and Joseph G. Ibrahim.

Biometrics·2024
Same author

A computationally efficient Bayesian seemingly unrelated regressions model for high-dimensional quantitative trait loci discovery.

Journal of the Royal Statistical Society. Series C, Applied statistics·2022
Same author

Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods.

PLoS computational biology·2021
Same author

GWAS on longitudinal growth traits reveals different genetic factors influencing infant, child, and adult BMI.

Science advances·2019

Related Experiment Video

Updated: Apr 14, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.1K

Borrowing from historical control data in a Bayesian time-to-event model with flexible baseline hazard function.

Darren A V Scott1, Alex Lewin2

  • 1Statistical Innovation, AstraZeneca R&D, Biomedical Campus, 1 Francis Crick Avenue, Cambridge, CB2 0AA, UK.

Biostatistics (Oxford, England)
|April 13, 2026
PubMed
Summary

This study introduces a flexible Bayesian semiparametric model for borrowing historical data in clinical trials. It improves statistical power and reduces bias by accurately modeling the baseline hazard, enhancing drug development efficiency.

Keywords:
Bayesian borrowingGaussian Markov random field priorcommensurate priormixture priorstime-to-event

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K

Related Experiment Videos

Last Updated: Apr 14, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.1K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Pharmacometrics

Background:

  • Statistical methods leveraging historical trial data accelerate drug discovery and development.
  • Bayesian methods offer dynamic borrowing, adjusting information incorporation based on data similarity.
  • Existing Bayesian borrowing methods often approximate baseline hazard shapes, potentially limiting accuracy.

Purpose of the Study:

  • To propose a novel Bayesian semiparametric model for borrowing information from one historical dataset.
  • To improve the accuracy of modeling the baseline hazard in time-to-event analyses.
  • To enhance statistical power and reduce bias in treatment effect estimation.

Main Methods:

  • Developed a Bayesian semiparametric model allowing unrestricted baseline hazard forms via an ensemble average.
  • Introduced smoothing priors for the posterior baseline hazard to enhance estimation and borrowing.
  • Explored various prior borrowing structures, including a lump-and-smear prior.
  • Proposed a principled method for selecting hyperparameters to control dynamic borrowing.

Main Results:

  • The proposed model improves power and reduces bias in treatment effect estimation when exchangeability holds.
  • Accurate baseline hazard modeling, rather than approximation, is key to effective borrowing.
  • The model reduces type I error inflation in the presence of prior-data conflict.
  • The lump-and-smear prior demonstrated benefits in improving type I error and power.

Conclusions:

  • The novel Bayesian semiparametric model offers a more accurate and flexible approach to borrowing historical data.
  • This method enhances clinical trial efficiency by improving statistical power and reliability.
  • Accompanying R software facilitates the implementation of this advanced statistical approach in practice.